John Gallacher - Vision for wales
•
1 like•549 views
Cardiff University Healthy Ageing Conference & Public Lecture The importance of a healthy lifestyle A Conference and a Public Lecture Thursday 30th October 2014 http://medicine.cardiff.ac.uk/event/healthy-ageing-conference-public-lecture/
Report
Share
Report
Share
Download to read offline
Recommended
Sue Hill (CSO) - Reflections #HCS15
Chief Scientific Officer for England Professor Sue Hill's closing reflections from the Tuesday session of the CSO #HCS15 2015 Annual Conference
Anne-Marie Coriat strategic approach to capacity & skills gaps in scientifi...
The document discusses strategic approaches to addressing capacity and skills gaps in scientific research. It summarizes the Medical Research Council's (MRC) mission to improve human health through funding excellent biomedical research. The MRC supports developing skills in strategic areas like molecular pathology and antimicrobial resistance. It has invested in various initiatives to build the UK research base and workforce, such as the Dementias Platform UK, UK Regenerative Medicine Platform, and cross-council programs on antimicrobial resistance. The MRC aims to maintain the UK's world-leading position in research through long-term investment and collaboration.
Mark Walport (Govt Office for Science) - Innovation, managing risk not avoidi...
This document discusses managing risk from innovation rather than avoiding it. It argues that innovation has led to many benefits but also risks that must be addressed. Risk is a societal issue that requires open discussion of how benefits and risks are distributed. Specific innovations need to be discussed rather than general technologies. Science can help by providing evidence but many issues involve both science and human values. Effective management of risk from innovation requires addressing these complex issues.
Barbara Wood - Partnership working patients, public & the community #hcs15
This document discusses partnership between patients, the public, and healthcare professionals and scientists. It argues that true partnership requires equal participation from all parties in planning and delivering healthcare. The future patient will be more informed about their health through technology, will manage their own care through access to online records and test results, and will have more choices. Healthcare scientists can partner with patients by making complex medical data understandable and by codesigning new models of integrated care delivery. Examples of current partnership initiatives include PatientView, which allows patients to access test results online, and a patient-held record developed together for thalassemia patients. Moving forward will require embracing new roles for healthcare scientists that leverage their skills and involving all stakeholders in redesigning healthcare systems
Darren Clark (Medilinks) Healthcare scientists partnerships with industry h...
Dr Darren Clark's presentation to the Monday session of the Chief Scientific Officer's #HCS15 2015 Annual Conference
Stephen Rosevear (Cogent SSC) - developing skills in life science nhs scient...
Stephen Rosevear's presentation to the Monday session of the Chief Scientific Officer's #HCS15 2015 Annual Conference
Keith Ison (Guy's & St Thomas' Hospital) The healthcare science workforce c...
Dr Keith Ison's presentation to the Monday session of the Chief Scientific Officer's #HCS15 2015 Annual Conference
Towse ISPOR Incoming President's Remarks
Adrian Towse outlined four priorities for his term as ISPOR President: 1) continuing globalization of ISPOR; 2) responding to growing payer demand for evidence of value; 3) raising HEOR scientific standards; and 4) supporting the next generation of researchers. He noted that ISPOR must anticipate diverse health systems' different challenges and respond to their needs by breaking out of narrow perspectives. Providing efficient healthcare globally requires understanding decision-making in different countries and using tools like HTA to support universal coverage in a way that incentivizes better outcomes and performance measurement.
Recommended
Sue Hill (CSO) - Reflections #HCS15
Chief Scientific Officer for England Professor Sue Hill's closing reflections from the Tuesday session of the CSO #HCS15 2015 Annual Conference
Anne-Marie Coriat strategic approach to capacity & skills gaps in scientifi...
The document discusses strategic approaches to addressing capacity and skills gaps in scientific research. It summarizes the Medical Research Council's (MRC) mission to improve human health through funding excellent biomedical research. The MRC supports developing skills in strategic areas like molecular pathology and antimicrobial resistance. It has invested in various initiatives to build the UK research base and workforce, such as the Dementias Platform UK, UK Regenerative Medicine Platform, and cross-council programs on antimicrobial resistance. The MRC aims to maintain the UK's world-leading position in research through long-term investment and collaboration.
Mark Walport (Govt Office for Science) - Innovation, managing risk not avoidi...
This document discusses managing risk from innovation rather than avoiding it. It argues that innovation has led to many benefits but also risks that must be addressed. Risk is a societal issue that requires open discussion of how benefits and risks are distributed. Specific innovations need to be discussed rather than general technologies. Science can help by providing evidence but many issues involve both science and human values. Effective management of risk from innovation requires addressing these complex issues.
Barbara Wood - Partnership working patients, public & the community #hcs15
This document discusses partnership between patients, the public, and healthcare professionals and scientists. It argues that true partnership requires equal participation from all parties in planning and delivering healthcare. The future patient will be more informed about their health through technology, will manage their own care through access to online records and test results, and will have more choices. Healthcare scientists can partner with patients by making complex medical data understandable and by codesigning new models of integrated care delivery. Examples of current partnership initiatives include PatientView, which allows patients to access test results online, and a patient-held record developed together for thalassemia patients. Moving forward will require embracing new roles for healthcare scientists that leverage their skills and involving all stakeholders in redesigning healthcare systems
Darren Clark (Medilinks) Healthcare scientists partnerships with industry h...
Dr Darren Clark's presentation to the Monday session of the Chief Scientific Officer's #HCS15 2015 Annual Conference
Stephen Rosevear (Cogent SSC) - developing skills in life science nhs scient...
Stephen Rosevear's presentation to the Monday session of the Chief Scientific Officer's #HCS15 2015 Annual Conference
Keith Ison (Guy's & St Thomas' Hospital) The healthcare science workforce c...
Dr Keith Ison's presentation to the Monday session of the Chief Scientific Officer's #HCS15 2015 Annual Conference
Towse ISPOR Incoming President's Remarks
Adrian Towse outlined four priorities for his term as ISPOR President: 1) continuing globalization of ISPOR; 2) responding to growing payer demand for evidence of value; 3) raising HEOR scientific standards; and 4) supporting the next generation of researchers. He noted that ISPOR must anticipate diverse health systems' different challenges and respond to their needs by breaking out of narrow perspectives. Providing efficient healthcare globally requires understanding decision-making in different countries and using tools like HTA to support universal coverage in a way that incentivizes better outcomes and performance measurement.
Lessons from the INDEPTH network: Moving from project to institutional approach
Lessons from the INDEPTH network: Moving from project to institutional approachUNICEF Office of Research - Innocenti
A presentation by Osman Sankoh as part of the Sustainability and Ownership panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014Rachel Munton (AHSN Network) Working with Academic Health Science Networks h...
Prof Rachel Munton's presentation to the Monday session of the Chief Scientific Officer's #HCS15 2015 Annual Conference
UK millennium cohort study: Strategies to foster sustainability and ownership
UK millennium cohort study: Strategies to foster sustainability and ownershipUNICEF Office of Research - Innocenti
A presentation by Emla Fitzsimons as part of the Sustainability and Ownership panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014Samantha Robertson - NHMRC Perspectives on Increasing Access to Data from Pub...
Governments and industries all over the world are tackling the challenges and opportunities of ‘Big Data’. In view of these challenges, the key drivers of change in this area are the behaviour of researchers, the introduction of incentives or rewards and funding for data sharing infrastructure. Governments and taxpayers also expect a return on investment from the money spent on publically funded research. Building on and learning from the successes (and failures) of others need to be part of the research vernacular. Issues such as open access, data curation, handling of data, and sharing of that data are all matters on which the National Health and Medical Research Council (NHMRC) has an interest in. NHMRC works with the sector to develop best practise policies on such matters.
Samantha Robertson
Executive Director, NHMRC Evidence, Advice & Governance
Presented at the 2015 Wiley Publishing Seminar, 5 November, Melbourne, Australia.
752573
This document is a call for papers for a special issue of BioMed Research International on evidence-based public health. It discusses that public health decision making is complex, involving many inputs and the need for consensus. It states that while public health has achieved much in the past century, future success requires greater use of evidence-based approaches. Key aspects of an evidence-based public health approach include making decisions based on the best available evidence, using sound research methods, and engaging the community in the decision making process. An evidence-based approach could provide numerous benefits such as access to higher quality information and more successful prevention programs. The call invites researchers to submit papers on generating and implementing evidence-based public health knowledge and practices.
Esr5 chess orientation school poster v4 pdf
Esr5 chess orientation school poster v4 pdfCHESS, Marie Sklodowska-Curie Actions, ITN - Connected Health
Modelling of chronic patient physical - activity- related behaviour towards healthy lifestyle supportPoster slide show - PRIME Annual Meeting 2020
The document summarizes the aims, activities, and plans of multiple research work packages within an organization over the past year and for the forthcoming year. Some of the key highlights mentioned include securing funding for trials and studies on topics like antibiotic prescribing and COVID-19, submitting applications for funding new research, and completing or making progress on ongoing research studies. The work packages plan to continue their research programs, pursue additional funding, and engage with partners to address healthcare needs over the coming year.
ESR 7 Caoimhe Bennis CHESS orientation conference poster
ESR 7 Caoimhe Bennis CHESS orientation conference posterCHESS, Marie Sklodowska-Curie Actions, ITN - Connected Health
The document discusses developing a digital education platform to support Interprofessional Education (IPE) for clinicians in primary health care. IPE brings different professions together to improve collaboration and quality of care. Research shows collaborative practice can decrease complications and errors while increasing patient satisfaction. The project will review current IPE models, interview clinicians, develop online modules and a platform, pilot the program, and evaluate it with clinicians.Brexit: What impact will it have on the UK's NHS and universities?
This presentation summarises some of the key impacts of Brexit on the UK's NHS and universities, public health in the UK, and the UK's life science industry.
Respiratory Futures webinar: Creative commissioning, the future is local (wit...
Many people in England have yet to grasp that there has been a major shift in how and where decisions about their healthcare are made. NHS reforms have resulted in a wholesale transfer of responsibility for commissioning decisions from the Department of Health (DH) to individual Clinical Commissioning Groups (CCGs) via NHS England.
Accountability for the majority of commissioning decisions that relate to respiratory disease now sits with CCGs and is not directed by either DH or NHS England.
The NHS in England is therefore a federation of over two hundred local commissioners who have effective autonomy over their commissioning priorities. In some areas, such as dementia or cancer, there are clear directives from NHS England, and a supporting structure in the form of strategic networks, to deliver standard service improvement.
For disease areas where these do not exist, CCGs have much greater choice in the nature and scale of service that they should provide. This has already led to variations in provision according to local need or simply by interest.
It is fast becoming clear that, unless there is a major political shift in emphasis, respiratory disease will not be prioritised specifically by NHS England, and CCGs will need to be influenced more explicitly by local need.
To a limited extent this is already happening where local stakeholder groups are interacting with CCGs in the form of an informal network and some individuals or groups of CCGs have already identified COPD as a priority in their five-year strategic plans. This is good news and likely to be successful, particularly if their proposed intentions fit in with the models suggested in the recently published Five Year Forward View which favours vertical integration and specialist interaction with primary care – see http://www.england.nhs.uk/ourwork/futurenhs/ for more details.
Whilst there is likely to be sufficient intrinsic justification for CCGs to develop sustained interest in respiratory conditions, this won’t happen automatically. There is still much to be done by us, as specialist healthcare professionals, to communicate consistently the importance of developing clinically led, patient-centred quality respiratory care to the 200 or so CCGs in England.
Health and Wellbeing Boards and local networks are an obvious conduit for influence. And around the country there are examples of patient organisations and stakeholder groups already having a positive influence on local commissioning policy, such as in Leeds and the South East Coast region.
Read more and continue the debate at http://www.respiratoryfutures.org.uk.
ESRC priorities in international development and longitudinal studies
ESRC priorities in international development and longitudinal studiesUNICEF Office of Research - Innocenti
A presentation by Craig Bardsley as part of the Sustainability and Ownership panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014Carolyn Wallace WSSPR - PRIME Annual Meeting 2020
Plenary presentation at the 2020 annual meeting for Wales School for Primary & Emergency Care Research (PRIME Centre Wales)
Welcome and introduction - successes, limitations and forward vision - Richar...
Welcome and introduction - successes, limitations and forward vision - Richar...NIHR CLAHRC West Midlands
Prof Richard Lilford's presentation on the year that was for the CLAHRC WM Matched Funders Forum, 9th June 2015, Birmingham, UKSarah Vibert, policy the next 21 years
The document discusses strategies for influencing neurological health policy in the UK over the next 21 years. It outlines how the health system has changed over the past 10-20 years, with reforms decentralizing power to local clinical commissioning groups and increasing patient choice and voice. It then provides recommendations for influencing policy nationally through engaging with government bodies and locally by working with regional stakeholders. It acknowledges uncertainties like Brexit but hopes that over the next 20 years continued efficiency, patient empowerment, and grassroots involvement can improve timely diagnoses, patient-centered care, treatment excellence, and benefit from scientific advances.
Funding Public health research in the UK. Professor Stephen Peckham
The document discusses public health research funding in the UK. It describes the different organizations that fund and conduct public health research, including Public Health England, local authorities, NHS Scotland, and others. It explains why public health research is needed to determine effective interventions, understand health behaviors, and evaluate public health services. The National Institute for Health Research is a major funder of applied health and clinical research through various programs.
An Overview
This is an invited presentation to a British Psychological Society symposium on Prevention,which seeks to summarise key English policy trends on prevention, and help develop the BPS position on the contribution of psychological science to government policy on Prevention
Benefits case study summary: Diabetes Uk Putting Feet First Campaign
Benefits case study summary: Diabetes Uk Putting Feet First CampaignThe Health and Social Care Information Centre
A benefits case study describing how Diabetes UK has used HSCIC's data and statistical outputs to inform the Putting Feet First campaign. https://www.diabetes.org.uk/Get_involved/Campaigning/Our-campaigns/Putting-feet-first/What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVEuropean Centre for Disease Prevention and Control
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Annette Verster, WHO
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030. BRIDGE_FOLDER_def
The BRIDGE Health project involves 31 institutes from 16 European countries. It aims to develop a strategic policy paper and technical blueprints for a future integrated European health information system covering both public health and healthcare. The project will disseminate results through technical reports, workshops, and meetings to target audiences like policymakers, researchers, and the general public. It seeks to ensure sustainability of health information activities and enhance synergy between domains like population health monitoring, disease registries, and clinical data collection.
NHS 5 Year Forward View
The document summarizes the key themes of the NHS 5 Year Forward View plan. It outlines the plan's vision for new models of integrated care focused on populations of 50,000 people. The plan acknowledges an estimated annual funding gap of £30 billion by 2020/21 for the NHS and the need for efficiency savings and increased funding. It also emphasizes the importance of prevention, personalization, technology, and social determinants of health for a sustainable healthcare system.
Paul Myers presentation WSPCR 2011
1) The document discusses using data from GP practices in Wales to analyze health conditions and identify areas of good and poor health. It summarizes data on conditions like stroke, heart disease, hypertension, diabetes, asthma, and COPD.
2) The data shows some variation in condition prevalence between local areas and GP practices. For example, the prevalence of stroke ranges from 1.0-1.6% between local authorities.
3) While condition prevalence generally correlates with deprivation levels, some inconsistencies exist, such as relatively low diagnosed stroke in one area. Overall the data provides insights but some weaknesses in correlations are present.
Welcome & Introduction - PRIME Centre Wales
The PRIME Centre Wales held its first annual meeting on September 22, 2015 at the Wales Millennium Centre. The summary discusses:
1) The meeting focused on collaborating, listening, and engaging to conduct high quality research that influences policy and practice in primary care, emergency care, and social care.
2) The PRIME Centre Wales is a collaboration between several Welsh universities aimed at improving health through research, influencing policy, and knowledge translation.
3) Upcoming events were announced that bring together researchers and stakeholders from health and social care to discuss research priorities in long term conditions, social care, and other areas.
More Related Content
What's hot
Lessons from the INDEPTH network: Moving from project to institutional approach
Lessons from the INDEPTH network: Moving from project to institutional approachUNICEF Office of Research - Innocenti
A presentation by Osman Sankoh as part of the Sustainability and Ownership panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014Rachel Munton (AHSN Network) Working with Academic Health Science Networks h...
Prof Rachel Munton's presentation to the Monday session of the Chief Scientific Officer's #HCS15 2015 Annual Conference
UK millennium cohort study: Strategies to foster sustainability and ownership
UK millennium cohort study: Strategies to foster sustainability and ownershipUNICEF Office of Research - Innocenti
A presentation by Emla Fitzsimons as part of the Sustainability and Ownership panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014Samantha Robertson - NHMRC Perspectives on Increasing Access to Data from Pub...
Governments and industries all over the world are tackling the challenges and opportunities of ‘Big Data’. In view of these challenges, the key drivers of change in this area are the behaviour of researchers, the introduction of incentives or rewards and funding for data sharing infrastructure. Governments and taxpayers also expect a return on investment from the money spent on publically funded research. Building on and learning from the successes (and failures) of others need to be part of the research vernacular. Issues such as open access, data curation, handling of data, and sharing of that data are all matters on which the National Health and Medical Research Council (NHMRC) has an interest in. NHMRC works with the sector to develop best practise policies on such matters.
Samantha Robertson
Executive Director, NHMRC Evidence, Advice & Governance
Presented at the 2015 Wiley Publishing Seminar, 5 November, Melbourne, Australia.
752573
This document is a call for papers for a special issue of BioMed Research International on evidence-based public health. It discusses that public health decision making is complex, involving many inputs and the need for consensus. It states that while public health has achieved much in the past century, future success requires greater use of evidence-based approaches. Key aspects of an evidence-based public health approach include making decisions based on the best available evidence, using sound research methods, and engaging the community in the decision making process. An evidence-based approach could provide numerous benefits such as access to higher quality information and more successful prevention programs. The call invites researchers to submit papers on generating and implementing evidence-based public health knowledge and practices.
Esr5 chess orientation school poster v4 pdf
Esr5 chess orientation school poster v4 pdfCHESS, Marie Sklodowska-Curie Actions, ITN - Connected Health
Modelling of chronic patient physical - activity- related behaviour towards healthy lifestyle supportPoster slide show - PRIME Annual Meeting 2020
The document summarizes the aims, activities, and plans of multiple research work packages within an organization over the past year and for the forthcoming year. Some of the key highlights mentioned include securing funding for trials and studies on topics like antibiotic prescribing and COVID-19, submitting applications for funding new research, and completing or making progress on ongoing research studies. The work packages plan to continue their research programs, pursue additional funding, and engage with partners to address healthcare needs over the coming year.
ESR 7 Caoimhe Bennis CHESS orientation conference poster
ESR 7 Caoimhe Bennis CHESS orientation conference posterCHESS, Marie Sklodowska-Curie Actions, ITN - Connected Health
The document discusses developing a digital education platform to support Interprofessional Education (IPE) for clinicians in primary health care. IPE brings different professions together to improve collaboration and quality of care. Research shows collaborative practice can decrease complications and errors while increasing patient satisfaction. The project will review current IPE models, interview clinicians, develop online modules and a platform, pilot the program, and evaluate it with clinicians.Brexit: What impact will it have on the UK's NHS and universities?
This presentation summarises some of the key impacts of Brexit on the UK's NHS and universities, public health in the UK, and the UK's life science industry.
Respiratory Futures webinar: Creative commissioning, the future is local (wit...
Many people in England have yet to grasp that there has been a major shift in how and where decisions about their healthcare are made. NHS reforms have resulted in a wholesale transfer of responsibility for commissioning decisions from the Department of Health (DH) to individual Clinical Commissioning Groups (CCGs) via NHS England.
Accountability for the majority of commissioning decisions that relate to respiratory disease now sits with CCGs and is not directed by either DH or NHS England.
The NHS in England is therefore a federation of over two hundred local commissioners who have effective autonomy over their commissioning priorities. In some areas, such as dementia or cancer, there are clear directives from NHS England, and a supporting structure in the form of strategic networks, to deliver standard service improvement.
For disease areas where these do not exist, CCGs have much greater choice in the nature and scale of service that they should provide. This has already led to variations in provision according to local need or simply by interest.
It is fast becoming clear that, unless there is a major political shift in emphasis, respiratory disease will not be prioritised specifically by NHS England, and CCGs will need to be influenced more explicitly by local need.
To a limited extent this is already happening where local stakeholder groups are interacting with CCGs in the form of an informal network and some individuals or groups of CCGs have already identified COPD as a priority in their five-year strategic plans. This is good news and likely to be successful, particularly if their proposed intentions fit in with the models suggested in the recently published Five Year Forward View which favours vertical integration and specialist interaction with primary care – see http://www.england.nhs.uk/ourwork/futurenhs/ for more details.
Whilst there is likely to be sufficient intrinsic justification for CCGs to develop sustained interest in respiratory conditions, this won’t happen automatically. There is still much to be done by us, as specialist healthcare professionals, to communicate consistently the importance of developing clinically led, patient-centred quality respiratory care to the 200 or so CCGs in England.
Health and Wellbeing Boards and local networks are an obvious conduit for influence. And around the country there are examples of patient organisations and stakeholder groups already having a positive influence on local commissioning policy, such as in Leeds and the South East Coast region.
Read more and continue the debate at http://www.respiratoryfutures.org.uk.
ESRC priorities in international development and longitudinal studies
ESRC priorities in international development and longitudinal studiesUNICEF Office of Research - Innocenti
A presentation by Craig Bardsley as part of the Sustainability and Ownership panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014Carolyn Wallace WSSPR - PRIME Annual Meeting 2020
Plenary presentation at the 2020 annual meeting for Wales School for Primary & Emergency Care Research (PRIME Centre Wales)
Welcome and introduction - successes, limitations and forward vision - Richar...
Welcome and introduction - successes, limitations and forward vision - Richar...NIHR CLAHRC West Midlands
Prof Richard Lilford's presentation on the year that was for the CLAHRC WM Matched Funders Forum, 9th June 2015, Birmingham, UKSarah Vibert, policy the next 21 years
The document discusses strategies for influencing neurological health policy in the UK over the next 21 years. It outlines how the health system has changed over the past 10-20 years, with reforms decentralizing power to local clinical commissioning groups and increasing patient choice and voice. It then provides recommendations for influencing policy nationally through engaging with government bodies and locally by working with regional stakeholders. It acknowledges uncertainties like Brexit but hopes that over the next 20 years continued efficiency, patient empowerment, and grassroots involvement can improve timely diagnoses, patient-centered care, treatment excellence, and benefit from scientific advances.
Funding Public health research in the UK. Professor Stephen Peckham
The document discusses public health research funding in the UK. It describes the different organizations that fund and conduct public health research, including Public Health England, local authorities, NHS Scotland, and others. It explains why public health research is needed to determine effective interventions, understand health behaviors, and evaluate public health services. The National Institute for Health Research is a major funder of applied health and clinical research through various programs.
An Overview
This is an invited presentation to a British Psychological Society symposium on Prevention,which seeks to summarise key English policy trends on prevention, and help develop the BPS position on the contribution of psychological science to government policy on Prevention
Benefits case study summary: Diabetes Uk Putting Feet First Campaign
Benefits case study summary: Diabetes Uk Putting Feet First CampaignThe Health and Social Care Information Centre
A benefits case study describing how Diabetes UK has used HSCIC's data and statistical outputs to inform the Putting Feet First campaign. https://www.diabetes.org.uk/Get_involved/Campaigning/Our-campaigns/Putting-feet-first/What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVEuropean Centre for Disease Prevention and Control
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Annette Verster, WHO
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030. BRIDGE_FOLDER_def
The BRIDGE Health project involves 31 institutes from 16 European countries. It aims to develop a strategic policy paper and technical blueprints for a future integrated European health information system covering both public health and healthcare. The project will disseminate results through technical reports, workshops, and meetings to target audiences like policymakers, researchers, and the general public. It seeks to ensure sustainability of health information activities and enhance synergy between domains like population health monitoring, disease registries, and clinical data collection.
NHS 5 Year Forward View
The document summarizes the key themes of the NHS 5 Year Forward View plan. It outlines the plan's vision for new models of integrated care focused on populations of 50,000 people. The plan acknowledges an estimated annual funding gap of £30 billion by 2020/21 for the NHS and the need for efficiency savings and increased funding. It also emphasizes the importance of prevention, personalization, technology, and social determinants of health for a sustainable healthcare system.
What's hot (20)
Lessons from the INDEPTH network: Moving from project to institutional approach
Lessons from the INDEPTH network: Moving from project to institutional approach
Rachel Munton (AHSN Network) Working with Academic Health Science Networks h...
Rachel Munton (AHSN Network) Working with Academic Health Science Networks h...
UK millennium cohort study: Strategies to foster sustainability and ownership
UK millennium cohort study: Strategies to foster sustainability and ownership
Samantha Robertson - NHMRC Perspectives on Increasing Access to Data from Pub...
Samantha Robertson - NHMRC Perspectives on Increasing Access to Data from Pub...
ESR 7 Caoimhe Bennis CHESS orientation conference poster
ESR 7 Caoimhe Bennis CHESS orientation conference poster
Brexit: What impact will it have on the UK's NHS and universities?
Brexit: What impact will it have on the UK's NHS and universities?
Respiratory Futures webinar: Creative commissioning, the future is local (wit...
Respiratory Futures webinar: Creative commissioning, the future is local (wit...
ESRC priorities in international development and longitudinal studies
ESRC priorities in international development and longitudinal studies
Welcome and introduction - successes, limitations and forward vision - Richar...
Welcome and introduction - successes, limitations and forward vision - Richar...
Funding Public health research in the UK. Professor Stephen Peckham
Funding Public health research in the UK. Professor Stephen Peckham
Benefits case study summary: Diabetes Uk Putting Feet First Campaign
Benefits case study summary: Diabetes Uk Putting Feet First Campaign
What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
Viewers also liked
Paul Myers presentation WSPCR 2011
1) The document discusses using data from GP practices in Wales to analyze health conditions and identify areas of good and poor health. It summarizes data on conditions like stroke, heart disease, hypertension, diabetes, asthma, and COPD.
2) The data shows some variation in condition prevalence between local areas and GP practices. For example, the prevalence of stroke ranges from 1.0-1.6% between local authorities.
3) While condition prevalence generally correlates with deprivation levels, some inconsistencies exist, such as relatively low diagnosed stroke in one area. Overall the data provides insights but some weaknesses in correlations are present.
Welcome & Introduction - PRIME Centre Wales
The PRIME Centre Wales held its first annual meeting on September 22, 2015 at the Wales Millennium Centre. The summary discusses:
1) The meeting focused on collaborating, listening, and engaging to conduct high quality research that influences policy and practice in primary care, emergency care, and social care.
2) The PRIME Centre Wales is a collaboration between several Welsh universities aimed at improving health through research, influencing policy, and knowledge translation.
3) Upcoming events were announced that bring together researchers and stakeholders from health and social care to discuss research priorities in long term conditions, social care, and other areas.
Colin dayan commercial research in cardiovascular disease
This document discusses establishing Cardiff University and surrounding NHS hospitals as a commercial research "hub" for cardiovascular clinical trials. It outlines why cardiovascular disease is a priority area for commercial drug development. Developing a strong reputation with industry would require accelerating trial set-up times, incentivizing staff to refer eligible patients, and providing high-quality principal investigators. The needs of clinicians include protected time, regulatory support, and infrastructure for trial delivery. The document proposes a coordination group called Cardiovascular Research Group - Cymru to facilitate collaborative translational research and multi-center trials across institutions. Establishing clear points of contact and minimizing delays could help deliver studies effectively. An example trial mentioned is the ODYSSEY trial of a P
Joyce kenkre sewahsp workshop
This document provides an agenda for an industry workshop hosted by the South East Wales Academic Health Science Partnership. The workshop will bring together stakeholders from industry, academia, and healthcare to discuss opportunities for collaboration on translational research. The morning session will include messages on how the region can succeed and perspectives on industry research prospects. Attendees will then break into workshops before reconvening for panel discussions. The afternoon will focus on the needs of clinicians and technology sectors, challenges and opportunities for research, and planning future collaborations to improve health and drive economic growth through innovation.
Helen Lester presentation WSPCR 2011
Helen Lester presented on the role of pay for performance (P4P) in quality improvement in the UK. She discussed how P4P was introduced in the UK in 2004 to improve quality of care and address issues like variations in care. While P4P led to improved achievement on incentivized measures, it also resulted in unintended consequences like increased transaction costs, changes to roles of nurses and doctors, and less attention to non-incentivized areas. Studies on the impact of P4P on outcomes have shown mixed results. Overall, P4P has improved some aspects of care but its high costs, impacts on relationships, and narrow focus raise questions about its long-term role in quality improvement.
Tony Jewell presentation WSPCR 2011
The document summarizes key points from a primary care and public health symposium presented by Dr. Tony Jewell, Chief Medical Officer for Wales. The symposium discussed: 1) the importance of primary care now more than ever; 2) the systematic application of evidence; 3) having the right tools for primary care providers' jobs; 4) opportunities to improve primary care through an integrated system; and 5) developing the right type of primary care systems. The document emphasizes the complexity of primary care according to Barbara Starfield and concludes by thanking attendees.
Pace study training slides 22 09-2015 v2.1
Primary care use of a C-Reactive Protein (CRP) Point of Care Test (POCT) to help target antibiotic prescribing to patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) who are most likely to benefit.
Viewers also liked (7)
Colin dayan commercial research in cardiovascular disease
Colin dayan commercial research in cardiovascular disease
Similar to John Gallacher - Vision for wales
Presentación NHS
Fenin en colaboración con el departamento comercial UK Trade and Investment, de la Embajada británica en Madrid, han organizado un foro empresarial dirigido al sector de tecnología sanitaria, con el objetivo de evaluar los sistemas de compras de los sistemas sanitarios de España y Reino Unido (NHS), y conocer las oportunidades de negocio que el NHS representa para empresas españolas de tecnología sanitaria.
Getting to grips with Population Health - 28th Feb 2018
A set of slides produced by Thames Valley Strategic Clinical Network to support the familiarisation event on Population Health held in Maidenhead on Wednesday 28th February 2018.
With thanks to all colleagues, attendees, chairs and speakers for their involvement on the day.
James Carter - Senior Network Manager TVSCN
james.carter1@nhs.net
Leicester - Patients in Control
The document discusses increasing patient participation in their treatment and care through personal health budgets. It provides evidence that activating patients through shared decision making, self-management support, and personal health budgets can lead to better health outcomes and lower costs. The presentation outlines plans to expand personal health budgets for those with long-term conditions in accordance with NHS objectives. It highlights early positive results from personal health budget trials showing improved quality of life and independence.
Ged byrne
Research for All: Now is the time!! advocates that now is a prime opportunity for increased research efforts due to several factors:
1) Demographic changes like an aging population and rising rates of chronic conditions are increasing healthcare needs and costs, highlighting the need for improved population health outcomes and more cost-effective care.
2) Technological advances, increased research emphasis and funding opportunities, and system changes like sustainability and transformation plans present opportunities to enhance research efforts and translate findings into policies and practices.
3) While healthcare systems face financial pressures, there are also burgeoning sources of research funding from industry, charitable organizations, and dedicated government funding that can be leveraged to support research without overburdening health
ABPI big data road map
The document outlines the opportunities and challenges presented by big data in healthcare. It notes that vast amounts of data are now being generated from sources like genome sequencing, electronic health records, social media, and patient websites. However, simply having large datasets does not guarantee value; the data needs to be analyzed and linked together to generate insights. The document discusses four levels of big data applications from processing large volumes of data to complex modeling. It also examines challenges like developing robust governance, embracing new data uses, overcoming data fragmentation, ensuring data quality and standards, developing innovative analytic methods, addressing skills shortages, and achieving returns on investment. The goal is to improve patient outcomes and healthcare cost-effectiveness through big data.
Towards a National Learning Health System - Aziz Sheikh
This document discusses moving from current ad-hoc healthcare systems to a national learning health system. It outlines challenges facing healthcare like rising costs and an aging population. Current digital health data is underused. Examples show how data can enable epidemiological research, evaluate policies, and support clinical trials. Bigger efforts are needed to create a prototype national asthma learning health system. This would use various data sources to monitor asthma burden, improve outcomes and reduce deaths. The goal is an integrated system that continuously learns from patient care to drive discovery and improve value.
Connected health cities
1. The document discusses creating learning health systems (LHS) that use data to continually improve healthcare delivery and establish a social contract to share data for public benefit.
2. It proposes connected health cities (CHC) pilots in four regions of Northern England to test LHS approaches and share knowledge between regions.
3. The goals are to optimize care delivery using data, engage the public on data sharing, and accelerate digital health business growth in Northern England.
Naja Warrer Iversen's presentation from the Healthcare DENMARK Ambassador Summit
The document outlines Denmark's new national health strategy, which aims to improve early diagnosis and treatment of diseases. It identifies five priority areas for investment over the next four years, totaling 5 billion kroner. The first priority is to detect cancer earlier through expanded screening and diagnostic testing, with a goal of 75% of cancer patients surviving five years after diagnosis by 2025. The second priority is to detect chronic diseases like diabetes and COPD earlier, through health checks and clearer treatment plans, with a target of reducing emergency admissions for those diseases by 20% by 2025.
Be Clear on Cancer awareness event - London 10 September 2013
A series of Be Clear on Cancer awareness events were held prior to the campaign launch in Autumn 2013. These slides are from the London event on 10 September 2012
The events included:
An update on the 'Blood in Pee' campaign Oct-Nov 2013
Sharing experiences from BCOC pilots
A review of the impact of the BCOC campaigns
Latest plans for BCOC February 20145 campaigns
An opportunity for delegates to feedback on experience of campaigns and make suggestions for improvement
Events were aimed at SCNs - Programme leads, Clinicians, Public Health, National NAEDI Partners - DH, Public Health England, NHS England and Charities
Be clear on cancer Leeds event September 2013
A series of Be Clear on Cancer awareness events were held prior to the campaign launch in Autumn 2013. These slides are from the Leeds event on 4 September 2012
The events included
An update on the 'Blood in Pee' campaign Oct-Nov 2013
Sharing experiences from BCOC pilots
A review of the impact of the BCOC campaigns
Latest plans for BCOC February 20145 campaigns
An opportunity for delegates to feedback on experience of campaigns and make suggestions for improvement
Events were aimed at SCNs - Programme leads, Clinicians, Public Health, National NAEDI Partners - DH, Public Health England, NHS England and Charities
Orphan Drugs – High Prices: Is there a Way Forward?
Graham was invited to the weekly seminar series by the Royal Brompton Hospital to deliver a presentation on health economics pertinent to Respiratory medicine. They care for a large number of patients with complex lung diseases at the institution and juggle the varied issues of resource (human, structural or financial). As one of many examples, high cost drugs for treating relatively unusual conditions comes up for debate all too frequently. The audience included consultant physicians, senior and junior trainees, nurses and other allied health professionals.
Date: 7 March 2019
Location: The Royal Brompton, London, UK
Roc ipposi dec2015 challenges and opportunities for clinical research
Challenges and opportunities for clinical research in Ireland - By Dr Rob O'Connor, Irish Cancer Society, Head of Research
What's new in the uk nsc
The document discusses the role and activities of the UK National Screening Committee (UK NSC). It provides that the UK NSC sets policy for systematic population screening programs in the UK based on criteria for effectiveness, acceptability, and cost. The document outlines challenges facing the UK NSC, including governance, membership, defining screening programs, and evidence review processes. It also discusses recent approvals of new screening programs and evidence reviews currently underway.
Data Visualization: New Health Data Value
Talk about data visualization as tool to add new value to health data, presented in the Panel: Old School Data Set, Rebooted, Repurposed and Creating Killer New Value Health Datapalooza, June 2, 2015
Lexington Health Practice 'The future of Market Access' Interactive Pamphlet
Lexington Health Practice recently held a breakfast event to discuss the future for market access in England. The breakfast, the first in a series, examined the Health Technology Appraisal (HTA) environment and facilitated a discussion amongst individuals who work closely with and amongst the pharmaceutical industry, examining how the mechanisms in place can be improved to ensure equitable access to medicines.
Psychology and the NHS Long Term Plan: Steming the Tide The centrality of pub...
Psychology and the NHS Long Term Plan: Steming the Tide The centrality of pub...Professor Jim McManus AFBPsS,FFPH,CSci, FRSB, CPsychol
This is an invited presentation to the British Psychological Society symposium on the NHS Long Term Plan and the role of Psychology within that. Integrated care and support
This document summarizes a presentation on integrated care and support given by representatives from NHS England and ADASS. It discusses the context of integration between health and social care services, identifies three "wicked issues" challenges to integration, and outlines next steps. Graphs and figures are included showing relationships between long-term conditions, costs of care, and the potential impact and cost savings of integrated models of care. The presentation addresses definitions of integration, evidence challenges, barriers such as information governance, and emphasizes the importance of person-centered coordinated care and building the capacity of patients to engage in self-management.
Investigation of barriers to the implementation of clinical trials in paralle...
This document summarizes barriers to implementing clinical trials in routine patient care settings. It discusses pressures on ward staff time and resources, lack of experience following research protocols, and cultural barriers like skepticism from nurses. It then reviews structures for clinical research in the UK, including the National Institute for Health Research, King's Health Partners Academic Health Sciences Centre, and regulations governing NHS research.
Foro calidad OPIMEC Richard Smith
Foro calidad OPIMEC Richard SmithObservatorio de Prácticas Innovadoras en el Manejo de Enfermedades Crónicas Complejas (OPIMEC)
1) The document discusses innovative approaches to preventing and managing complex chronic diseases, including establishing centers of excellence through a partnership between UnitedHealth and the National Heart, Lung, and Blood Institute.
2) It outlines "Grand Challenges" to address chronic disease through public awareness, policies, risk factor modification, business engagement, and health system reorientation.
3) Prevention efforts for those with complex chronic conditions face conceptual difficulties and should be patient-centered rather than disease-focused.SRNT-E 2016 Lindson-Hawley
Talk at SRNT Europe 2016, Prague on findings from CTAG taps. Specifically focused on dissemination of tobaco research
Similar to John Gallacher - Vision for wales (20)
Getting to grips with Population Health - 28th Feb 2018
Getting to grips with Population Health - 28th Feb 2018
Towards a National Learning Health System - Aziz Sheikh
Towards a National Learning Health System - Aziz Sheikh
Naja Warrer Iversen's presentation from the Healthcare DENMARK Ambassador Summit
Naja Warrer Iversen's presentation from the Healthcare DENMARK Ambassador Summit
Be Clear on Cancer awareness event - London 10 September 2013
Be Clear on Cancer awareness event - London 10 September 2013
Orphan Drugs – High Prices: Is there a Way Forward?
Orphan Drugs – High Prices: Is there a Way Forward?
Roc ipposi dec2015 challenges and opportunities for clinical research
Roc ipposi dec2015 challenges and opportunities for clinical research
Lexington Health Practice 'The future of Market Access' Interactive Pamphlet
Lexington Health Practice 'The future of Market Access' Interactive Pamphlet
Psychology and the NHS Long Term Plan: Steming the Tide The centrality of pub...
Psychology and the NHS Long Term Plan: Steming the Tide The centrality of pub...
Investigation of barriers to the implementation of clinical trials in paralle...
Investigation of barriers to the implementation of clinical trials in paralle...
More from angewatkins
11. Mark Kingston- Elevator pitch PRIME 2020
1) Ambulance services in the UK saw a significant increase in suspected COVID-19 incidents from February to July 2020, peaking at over 25,000 incidents per month.
2) The percentage of suspected COVID-19 patients conveyed to hospitals by ambulance services ranged from 32% to 54% across different services.
3) Ambulance services implemented new triage processes, recruited additional staff and clinical volunteers, and increased use of video consultations to manage the increased demand from the pandemic while keeping patients out of emergency departments when possible.
07. Stella Wright_App pacesetter project_Elevator pitch_PRIME 2020
The document discusses the impact of advanced paramedic practitioners in primary care in Wales. It found that advanced paramedic practitioners (APPs) were able to relieve pressure on GPs by taking on lower-acuity patient cases, allowing GPs to focus on more complex patients. The APPs gained experience in primary care settings, consulting a wider range of patients and developing better management plans. They also were able to share their primary care learnings with ambulance colleagues. Both primary care clusters and the Welsh Ambulance Service saw benefits to the APP role in primary care.
SUPER - PRIME Annual Meeting 2020
Plenary presentation at the 2020 annual meeting for Wales School for Primary & Emergency Care Research (PRIME Centre Wales)
Joyce Kenkre - PRIME Annual Meeting 2020
Plenary presentation at the 2020 annual meeting for Wales School for Primary & Emergency Care Research (PRIME Centre Wales)
Helen Snooks - PRIME Annual Meeting 2020
Plenary presentation at the 2020 annual meeting for Wales School for Primary & Emergency Care Research (PRIME Centre Wales)
Clare Wilkinson - PRIME Annual Meeting 2020
Plenary presentation at the 2020 annual meeting for Wales School for Primary & Emergency Care Research (PRIME Centre Wales)
Adrian Edwards - PRIME Annual Meeting 2020
Plenary presentation at the 2020 annual meeting for Wales School for Primary & Emergency Care Research (PRIME Centre Wales)
Improving support for women with musculoskeletal conditions during pregnancy,...
The document discusses support needs for women with musculoskeletal conditions during pregnancy, planning for pregnancy, and early parenting. It finds that women with long-term limiting illnesses are more likely to have unplanned pregnancies and negative pregnancy outcomes, and their children are more likely to develop illnesses. While the vast majority adapt well, targeted support with health behaviors could help outcomes. The document also examines challenges for women with chronic pain or autoimmune diseases parenting young children, and calls for more integrated care and information on pregnancy planning and parenting with these conditions.
Nefyn Williams_LTC Consensus Meeting 10-Nov-2015
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Judith Carrier_LTC Consensus Meeting 10-Nov-2015
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Joyce Kenkre & Carolyn Wallace _LTC Consensus Meeting 10-Nov-2015
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Age Alliances Wales_LTC Consensus Meeting 10-Nov-2015
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Richard Neal LTC _Consensus Meeting 10-Nov-2015
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Dan Venables_LTC Consensus Meeting 10-Nov-2015
PRIME Centre Wales
Long Term Conditions Consensus Meeting
Tuesday 10th November 2015, St Mary's Priory, Abergavenny, NP7 5ND
http://www.primecentre.wales/ltc-consensus-meeting.php
Adrian Edwards - PRIME Social Care Consensus Meeting 20151005
This document summarizes the PRIME Centre Wales, which aims to improve health and well-being in Wales through high-quality research and influencing policy. The Center will take a multi-disciplinary approach and focus on research areas like long-term conditions, patient-centered care, infections, screening and prevention, and emergency care. It will work with patients and public groups, social care services, industry partners, and other research groups in Wales. The leadership team is led by Professor Adrian Edwards of Cardiff University and includes representatives from Bangor, Swansea, and the University of South Wales.
PRIME Centre Wales - Overview
This document provides an overview of the Wales Centre for Primary & Emergency Care Research (PRIME Centre Wales). It describes the background and leadership team. The Centre aims to improve health through high quality primary and emergency care research. It has eight work packages focused on key areas like long term conditions, infections, and patient safety. The Centre will collaborate widely across universities, the NHS, social care services, patients, and industry. It hopes to increase research quantity and impact in Wales through activities like applying for funding, building capacity, and ensuring findings are implemented. The Centre has already achieved early successes in securing new grants.
Tony Bayer - Dementia prevention
Cardiff University Healthy Ageing Conference & Public Lecture
The importance of a healthy lifestyle
A Conference and a Public Lecture
Thursday 30th October 2014
http://medicine.cardiff.ac.uk/event/healthy-ageing-conference-public-lecture/
Stephen Rollnick - Motivating people
Cardiff University Healthy Ageing Conference & Public Lecture
The importance of a healthy lifestyle
A Conference and a Public Lecture
Thursday 30th October 2014
http://medicine.cardiff.ac.uk/event/healthy-ageing-conference-public-lecture/
Rhodri Martin - Physical activity
The document discusses the benefits of meditation for reducing stress and anxiety. Regular meditation practice can help calm the mind and body by lowering heart rate and blood pressure. Making meditation a part of a daily routine, even if just 10-15 minutes per day, can have mental and physical health benefits over time by reducing stress levels and promoting relaxation.
Peter Elwood - The success of the caerphilly cohort study
The Caerphilly Cohort Study has followed over 2,000 middle-aged men in Wales for 35 years, with follow-up examinations every five years. The study has led to over 400 research papers that have shown benefits of a healthy lifestyle like reduced risk of diabetes, heart disease, and dementia. However, uptake of healthy behaviors in Wales remains low, with only 5% following four to five healthy behaviors. The study highlights the potential for reducing disease burden in Wales if individuals adopt even one additional healthy behavior.
More from angewatkins (20)
07. Stella Wright_App pacesetter project_Elevator pitch_PRIME 2020
07. Stella Wright_App pacesetter project_Elevator pitch_PRIME 2020
Improving support for women with musculoskeletal conditions during pregnancy,...
Improving support for women with musculoskeletal conditions during pregnancy,...
Joyce Kenkre & Carolyn Wallace _LTC Consensus Meeting 10-Nov-2015
Joyce Kenkre & Carolyn Wallace _LTC Consensus Meeting 10-Nov-2015
Age Alliances Wales_LTC Consensus Meeting 10-Nov-2015
Age Alliances Wales_LTC Consensus Meeting 10-Nov-2015
Adrian Edwards - PRIME Social Care Consensus Meeting 20151005
Adrian Edwards - PRIME Social Care Consensus Meeting 20151005
Peter Elwood - The success of the caerphilly cohort study
Peter Elwood - The success of the caerphilly cohort study
Recently uploaded
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Journal Article Review on Rasamanikya
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxMGM SCHOOL/COLLEGE OF NURSING
Identification and nursing management of congenital malformations How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
STIs may cause PID. For the both disease, herbal medicine Fuyan Pill can be a solution.
NVBDCP.pptx Nation vector borne disease control program
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
Recently uploaded (20)
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
John Gallacher - Vision for wales
- 2. Wales as a public health laboratory Science as the testing of well-formed hypotheses Public health as the engagement of the public in their own health
- 3. Why Wales? • Distribution of inequality • Defined population • Devolved government • Developed infrastructure – NHS – Informatics – Research base
- 4. What are the benefits? • Health – Improved public health – Reduced health inequalities • Wealth – Greater productivity – Reduced health care costs – Greater inward investment
- 7. So, what’s the plan ! 1. Do good science 2. Use evidence to inform policy 3. Use policy to engage the public
- 8. Good science • Need for large-scale data resources to deliver definitive answers • Need to study basic mechanisms to develop new interventions • Need to reduce costs to make science more efficient
- 9. The need for large studies: CHD versus SBP in the Prospective Studies Collaboration (PSC) Usual SBP (mmHg) 120 140 160 180 1 2 4 8 16 32 64 128 256 Age at risk: 80-89 70-79 60-69 50-59 40-49 500,000 people Usual SBP (mmHg) 120 140 160 180 1 2 4 8 16 32 64 128 256 Age at risk: 80-89 70-79 60-69 50-59 40-49 50,000 people Usual SBP (mmHg) 120 140 160 180 1 2 4 8 16 32 64 128 256 Age at risk: 80-89 70-79 60-69 50-59 40-49 5000 people
- 11. Does it work?
- 14. Areas covered
- 15. Recruitment
- 19. What would success look like? “Better, cheaper and quicker science” “Better targeted and more effective public health” • Fully integrated use of health related information • Widespread participation in the cohort • Generous biosample donation • Profusion of high quality specialist studies • Improved public engagement with health • Increased inward investment